Structure Therapeutics Inc.·4

Mar 19, 4:46 PM ET

Bach Mark Allen 4

4 · Structure Therapeutics Inc. · Filed Mar 19, 2024

Insider Transaction Report

Form 4
Period: 2024-03-15
Bach Mark Allen
Chief Medical Officer
Transactions
  • Award

    Ordinary Shares

    2024-03-15+26,23526,235 total
  • Award

    Stock Option (right to buy)

    2024-03-15+65,35265,352 total
    Exercise: $35.25Exp: 2034-03-14Ordinary Shares (65,352 underlying)
Footnotes (2)
  • [F1]Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one ordinary share of the Issuer. The RSUs vest 1/4th annually on each anniversary of March 1, 2024, subject to Reporting Person's continued service on such dates.
  • [F2]1/4th of the shares subject to the option shall vest March 1, 2025, and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each such vesting date.

Documents

1 file
  • 4
    form4-03192024_080323.xmlPrimary